{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:19:20Z","timestamp":1772608760961,"version":"3.50.1"},"reference-count":149,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>The COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2), a respiratory pathogen with neuroinvasive potential. Neurological COVID-19 manifestations include loss of smell and taste, headache, dizziness, stroke, and potentially fatal encephalitis. Several studies found elevated proinflammatory cytokines, such as TNF-\u03b1, IFN-\u03b3, IL-6 IL-8, IL- 10 IL-16, IL-17A, and IL-18 in severely and critically ill COVID-19 patients may persist even after apparent recovery from infection. Biomarker studies on CSF and plasma and serum from COVID-19 patients have also shown a high level of IL-6, intrathecal IgG, neurofilament light chain (NFL), glial fibrillary acidic protein (GFAP), and tau protein. Emerging evidence on the matter has established the concept of COVID-19-associated neuroinflammation, in the context of COVID-19-associated cytokine storm. While the short-term implications of this condition are extensively documented, its longterm implications are yet to be understood. The association of the aforementioned cytokines with the pathogenesis of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, may increase COVID-19 patients' risk of developing neurodegenerative diseases. Analysis of proinflammatory cytokines and CSF biomarkers in patients with COVID-19 can contribute to the early detection of the disease's exacerbation, monitoring the neurological implications of the disease and devising risk scales, and identifying treatment targets.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1567205019666220908084559","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T05:51:46Z","timestamp":1662961906000},"page":"641-657","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-19"],"prefix":"10.2174","volume":"19","author":[{"given":"Christos","family":"Tsagkaris","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Crete, Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Bilal","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irem","family":"Aktar","sequence":"additional","affiliation":[{"name":"Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Aboufandi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Tas","sequence":"additional","affiliation":[{"name":"Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullahi Tunde","family":"Aborode","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Mississipi State University, Starkville, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun Kumar","family":"Suvvari","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Dr. NTR University of Health Sciences, Vijayawada, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoaib","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Punjab Medical College, Faisalabad, Pakistan"},{"name":"Faisalabad Medical University, Faisalabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasiia","family":"Shkodina","sequence":"additional","affiliation":[{"name":"Department of Neurological Diseases With Neurosurgery and Medical Genetics, Poltava State Medical University, Poltava, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Phadke","sequence":"additional","affiliation":[{"name":"School of Medicine, Indira Gandhi Government Medical College, Nagpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa S.","family":"Emhamed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Tripoli, Tripoli, Libya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atif Amin","family":"Baig","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Sultan Zainal Abidin University, Kuala Terengganu, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[{"name":"Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia"},{"name":"AFNP Med Austria, Wien 1010, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghulam Md.","family":"Ashraf","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, University City, Sharjah 27272, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amjad","family":"Kamal","sequence":"additional","affiliation":[{"name":"West China School of Nursing \/Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China"},{"name":"King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","volume":"11","author":"Tang Y.","year":"2020","unstructured":"Tang Y.; Liu J.; Zhang D.; Xu Z.; Ji J.; Wen C.; Cytokine storm in COVID-19: The current evidence and treatment strategies. Front Immunol 2020,11,1708","journal-title":"Front Immunol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"Horby P.","year":"2021","unstructured":"Horby P.; Lim W.S.; Emberson J.R.; Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021,384(8),693-704","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"28062","DOI":"10.1007\/s11356-021-18384-4","volume":"29","author":"Boiko D.I.","year":"2022","unstructured":"Boiko D.I.; Skrypnikov A.M.; Shkodina A.D.; Hasan M.M.; Ashraf G.M.; Rahman M.H.; Circadian rhythm disorder and anxiety as mental health complications in post-COVID-19. Environ Sci Pollut Res Int 2022,29(19),28062-28069","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4103\/joacp.JOACP_359_20","volume":"36","author":"Paul G.","year":"2020","unstructured":"Paul G.; Mahajan R.K.; Mahajan R.; Gautam P.; Paul B.; Systemic manifestations of COVID-19. J Anaesthesiol Clin Pharmacol 2020,36(4),435-442","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","volume":"14","author":"Bansal M.","year":"2020","unstructured":"Bansal M.; Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020,14(3),247-250","journal-title":"Diabetes Metab Syndr"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Xu Z.","year":"2020","unstructured":"Xu Z.; Shi L.; Wang Y.; Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020,8(4),420-422","journal-title":"Lancet Respir Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","volume":"201","author":"Gattinoni L.","year":"2020","unstructured":"Gattinoni L.; Coppola S.; Cressoni M.; Busana M.; Rossi S.; Chiumello D.; COVID-19 does not lead to a \u201ctypical\u201d acute respiratory distress syndrome. Am J Respir Crit Care Med 2020,201(10),1299-1300","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"Mao L.","year":"2020","unstructured":"Mao L.; Jin H.; Wang M.; Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020,77(6),683-690","journal-title":"JAMA Neurol"},{"key":"ref=9","first-page":"19","volume":"2020","author":"Sonja A.","year":"2020","unstructured":"Sonja A.; Rasmussen M.S.; Vaccine development against coronavirus (2003 to present): An overview, recent advances, current scenario, opportunities and challenges. Ann Oncol 2020,2020,19-21","journal-title":"Ann Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s00415-020-09951-9","volume":"267","author":"Parsons T.","year":"2020","unstructured":"Parsons T.; Banks S.; Bae C.; Gelber J.; Alahmadi H.; Tichauer M.; COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol 2020,267(10),2799-2802","journal-title":"J Neurol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12974-020-01957-4","volume":"17","author":"Jarrahi A.","year":"2020","unstructured":"Jarrahi A.; Ahluwalia M.; Khodadadi H.; Neurological consequences of COVID-19: What have we learned and where do we go from here? J Neuroinflammation 2020,17(1),286","journal-title":"J Neuroinflammation"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.3748\/wjg.v27.i26.4248","volume":"27","author":"Zhuang Y.P.","year":"2021","unstructured":"Zhuang Y.P.; Zhong H.J.; Impact of COVID-19 on the clinical status of patients with Wilson disease. World J Gastroenterol 2021,27(26),4248-4251","journal-title":"World J Gastroenterol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1743-422X-10-172","volume":"10","author":"Zhou L.","year":"2013","unstructured":"Zhou L.; Miranda-Saksena M.; Saksena N.K.; Viruses and neurodegeneration. Virol J 2013,10(1),172","journal-title":"Virol J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","volume":"129","author":"Amor S.","year":"2010","unstructured":"Amor S.; Puentes F.; Baker D.; van der Valk P.; Inflammation in neurodegenerative diseases. Immunology 2010,129(2),154-169","journal-title":"Immunology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; P\u00f6hlmann S.; A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell 2020,78(4),779-784.e5","journal-title":"Mol Cell"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"Yan R","year":"2020","unstructured":"Yan R; Zhang Y; Li Y; Xia L; Guo Y; Zhou Q; Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (80-) 2020,367,1444-8","journal-title":"Science (80-)"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1128\/JVI.03368-12","volume":"87","author":"Dijkman R.","year":"2013","unstructured":"Dijkman R.; Jebbink M.F.; Koekkoek S.M.; Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol 2013,87(11),6081-6090","journal-title":"J Virol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"Hamming I.","year":"2004","unstructured":"Hamming I.; Timens W.; Bulthuis M.L.C.; Lely A.T.; Navis G.J.; van Goor H.; Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004,203(2),631-637","journal-title":"J Pathol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"573095","DOI":"10.1101\/2020.04.07.030650","volume":"11","author":"Chen R.","year":"2020","unstructured":"Chen R.; Wang K.; Yu J.; The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain. BioRxiv 2020,11,573095","journal-title":"BioRxiv"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1073\/pnas.1217508110","volume":"110","author":"Espinoza J.A.","year":"2013","unstructured":"Espinoza J.A.; Bohmwald K.; C\u00e9spedes P.F.; Impaired learning resulting from Respiratory Syncytial Virus infection. Proc Natl Acad Sci USA 2013,110(22),9112-9117","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000324777","volume":"72","author":"Tsutsumi H.","year":"2011","unstructured":"Tsutsumi H.; Kojima T.; Hirakawa S.; Respiratory syncytial virus infection and the tight junctions of nasal epithelial cells. Adv Otorhinolaryngol 2011,72,153-156","journal-title":"Adv Otorhinolaryngol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s42399-020-00522-7","volume":"2","author":"Jakhmola S.","year":"2020","unstructured":"Jakhmola S.; Indari O.; Chatterjee S.; Jha H.C.; SARS-CoV-2, an underestimated pathogen of the nervous system. SN Compr Clin Med 2020,2(11),2137-2146","journal-title":"SN Compr Clin Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"Lochhead J.J.","year":"2012","unstructured":"Lochhead J.J.; Thorne R.G.; Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 2012,64(7),614-628","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/13550280590922793","volume":"11","author":"Mori I.","year":"2005","unstructured":"Mori I.; Nishiyama Y.; Yokochi T.; Kimura Y.; Olfactory transmission of neurotropic viruses. J Neurovirol 2005,11(2),129-137","journal-title":"J Neurovirol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2020.04.060","volume":"87","author":"Esposito G.","year":"2020","unstructured":"Esposito G.; Pesce M.; Seguella L.; Sanseverino W.; Lu J.; Sarnelli G.; Can the enteric nervous system be an alternative entrance door in SARS-CoV-2 neuroinvasion? Brain Behav Immun 2020,87,93-94","journal-title":"Brain Behav Immun"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.psychres.2019.07.005","volume":"279","author":"Allsopp K.","year":"2019","unstructured":"Allsopp K.; Read J.; Corcoran R.; Kinderman P.; Heterogeneity in psychiatric diagnostic classification. Psychiatry Res 2019,279,15-22","journal-title":"Psychiatry Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"102120","DOI":"10.1016\/j.msard.2020.102120","volume":"42","author":"Novi G.","year":"2020","unstructured":"Novi G.; Mikulska M.; Briano F.; COVID-19 in a MS patient treated with ocrelizumab: Does immunosuppression have a protective role? Mult Scler Relat Disord 2020,42,102120","journal-title":"Mult Scler Relat Disord"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-immunol-042718-041417","volume":"37","author":"Klein R.S.","year":"2019","unstructured":"Klein R.S.; Garber C.; Funk K.E.; Neuroinflammation during RNA viral infections. Annu Rev Immunol 2019,37(1),73-95","journal-title":"Annu Rev Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-3-319-60189-2_8","volume":"18","author":"Tjalkens R.B.","year":"2017","unstructured":"Tjalkens R.B.; Popichak K.A.; Kirkley K.A.; Inflammatory activation of microglia and astrocytes in manganese neurotoxicity. Adv Neurobiol 2017,18,159-181","journal-title":"Adv Neurobiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e20202135","DOI":"10.1084\/jem.20202135","volume":"218","author":"Song E.","year":"2021","unstructured":"Song E.; Zhang C.; Israelow B.; Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021,218(3),e20202135","journal-title":"J Exp Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1056\/NEJMc2008597","volume":"382","author":"Helms J.","year":"2020","unstructured":"Helms J.; Kremer S.; Merdji H.; Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020,382(23),2268-2270","journal-title":"N Engl J Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1212\/WNL.0000000000009937","volume":"95","author":"Romero-S\u00e1nchez C.M.","year":"2020","unstructured":"Romero-S\u00e1nchez C.M.; D\u00edaz-Maroto I.; Fern\u00e1ndez-D\u00edaz E.; Neurologic manifestations in hospitalized patients with COVID-19. Neurology 2020,95(8),e1060-e1070","journal-title":"Neurology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"104941","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104941","volume":"29","author":"Divani A.A.","year":"2020","unstructured":"Divani A.A.; Andalib S.; Di Napoli M.; Coronavirus disease 2019 and stroke: Clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis 2020,29(8),104941","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2020.05.013","volume":"18","author":"Saheb Sharif-Askari N.","year":"2020","unstructured":"Saheb Sharif-Askari N.; Saheb Sharif-Askari F.; Alabed M.; Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol Ther Methods Clin Dev 2020,18,1-6","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"573095","DOI":"10.3389\/fneur.2020.573095","volume":"11","author":"Chen R.","year":"2021","unstructured":"Chen R.; Wang K.; Yu J.; The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol 2021,11,573095","journal-title":"Front Neurol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e48910","DOI":"10.1371\/journal.pone.0048910","volume":"7","author":"Feng Y.","year":"2012","unstructured":"Feng Y.; Hans C.; McIlwain E.; Varner K.J.; Lazartigues E.; Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy. PLoS One 2012,7(11),e48910","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10571-020-00915-1","volume":"42","author":"Xu J.","year":"2022","unstructured":"Xu J.; Lazartigues E.; Expression of ACE2 in human neurons supports the neuro-invasive potential of COVID-19 virus. Cell Mol Neurobiol 2022,42(1),305-309","journal-title":"Cell Mol Neurobiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2001948","DOI":"10.1183\/13993003.01948-2020","volume":"56","author":"Chen M.","year":"2020","unstructured":"Chen M.; Shen W.; Rowan N.R.; Elevated ACE-2 expression in the olfactory neuroepithelium: Implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur Respir J 2020,56(3),2001948","journal-title":"Eur Respir J"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","volume":"24","author":"Meinhardt J.","year":"2021","unstructured":"Meinhardt J.; Radke J.; Dittmayer C.; Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021,24(2),168-175","journal-title":"Nat Neurosci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"105131","DOI":"10.1016\/j.nbd.2020.105131","volume":"146","author":"Buzhdygan T.P.","year":"2020","unstructured":"Buzhdygan T.P.; DeOre B.J.; Baldwin-Leclair A.; The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 2020,146,105131","journal-title":"Neurobiol Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","volume":"92","author":"Paniz-Mondolfi A.","year":"2020","unstructured":"Paniz-Mondolfi A.; Bryce C.; Grimes Z.; Central nervous system involvement by severe acute respiratory syndrome Coronavirus\u20102 (SARS\u2010CoV\u20102). J Med Virol 2020,92(7),699-702","journal-title":"J Med Virol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"Romano M.","year":"2020","unstructured":"Romano M.; Ruggiero A.; Squeglia F.; Maga G.; Berisio R.; A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells 2020,9(5),1267","journal-title":"Cells"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","volume":"11","author":"Shah V.K.","year":"2020","unstructured":"Shah V.K.; Firmal P.; Alam A.; Ganguly D.; Chattopadhyay S.; Overview of immune response during SARS-CoV-2 infection: Lessons from the past. Front Immunol 2020,11,1949","journal-title":"Front Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"Akira S.","year":"2006","unstructured":"Akira S.; Uematsu S.; Takeuchi O.; Pathogen recognition and innate immunity. Cell 2006,124(4),783-801","journal-title":"Cell"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"Ragab D.","year":"2020","unstructured":"Ragab D.; Salah Eldin H.; Taeimah M.; Khattab R.; Salem R.; The COVID-19 cytokine storm; What we know so far. Front Immunol 2020,11,1446","journal-title":"Front Immunol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"Zhang J.M.","year":"2007","unstructured":"Zhang J.M.; An J.; Cytokines, inflammation, and pain. Int Anesthesiol Clin 2007,45(2),27-37","journal-title":"Int Anesthesiol Clin"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","volume":"17","author":"Najjar S.","year":"2020","unstructured":"Najjar S.; Najjar A.; Chong D.J.; Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports. J Neuroinflammation 2020,17(1),231","journal-title":"J Neuroinflammation"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","volume":"163","author":"Cao L.","year":"2021","unstructured":"Cao L.; Mu W.; Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications. Pharmacol Res 2021,163,105297","journal-title":"Pharmacol Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"Mehta P.","year":"2020","unstructured":"Mehta P.; McAuley D.F.; Brown M.; Sanchez E.; Tattersall R.S.; Manson J.J.; COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020,395(10229),1033-1034","journal-title":"Lancet"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/ijerph18041415","volume":"18","author":"Fisicaro F.","year":"2021","unstructured":"Fisicaro F.; Di Napoli M.; Liberto A.; Neurological sequelae in patients with COVID-19: A histopathological perspective. Int J Environ Res Public Health 2021,18(4),1415","journal-title":"Int J Environ Res Public Health"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"Hoffmann M.","year":"2020","unstructured":"Hoffmann M.; Kleine-Weber H.; Schroeder S.; SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020,181(2),271-280.e8","journal-title":"Cell"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/j.1471-4159.2008.05723.x","volume":"107","author":"Xia H.","year":"2008","unstructured":"Xia H.; Lazartigues E.; Angiotensin-converting enzyme 2 in the brain: Properties and future directions. J Neurochem 2008,107(6),1482-1494","journal-title":"J Neurochem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"R373","DOI":"10.1152\/ajpregu.00292.2006","volume":"292","author":"Doobay M.F.","year":"2007","unstructured":"Doobay M.F.; Talman L.S.; Obr T.D.; Tian X.; Davisson R.L.; Lazartigues E.; Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2007,292(1),R373-R381","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"C1073","DOI":"10.1152\/ajpcell.00364.2012","volume":"304","author":"Xiao L.","year":"2013","unstructured":"Xiao L.; Haack K.K.V.; Zucker I.H.; Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1\/2 signaling. Am J Physiol Cell Physiol 2013,304(11),C1073-C1079","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12967-020-02571-x","volume":"18","author":"Zhang J.","year":"2020","unstructured":"Zhang J.; Hao Y.; Ou W.; Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: A cohort study. J Transl Med 2020,18(1),406","journal-title":"J Transl Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"Diao B.","year":"2020","unstructured":"Diao B.; Wang C.; Tan Y.; Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 2020,11,827","journal-title":"Front Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ijid.2020.10.003","volume":"101","author":"Nagant C.","year":"2020","unstructured":"Nagant C.; Ponthieux F.; Smet J.; A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. Int J Infect Dis 2020,101,342-345","journal-title":"Int J Infect Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","volume":"40","author":"Hojyo S.","year":"2020","unstructured":"Hojyo S.; Uchida M.; Tanaka K.; How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 2020,40(1),37","journal-title":"Inflamm Regen"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2147\/COPD.S164833","volume":"13","author":"Savchenko L.","year":"2018","unstructured":"Savchenko L.; Mykytiuk M.; Cinato M.; Tronchere H.; Kunduzova O.; Kaidashev I.; IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients. Int J Chron Obstruct Pulmon Dis 2018,13,2569-2575","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41598-021-82426-7","volume":"11","author":"Caterino M.","year":"2021","unstructured":"Caterino M.; Gelzo M.; Sol S.; Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci Rep 2021,11(1),2941","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"a006148","DOI":"10.1101\/cshperspect.a006148","volume":"2","author":"Tarawneh R.","year":"2012","unstructured":"Tarawneh R.; Holtzman D.M.; The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med 2012,2(5),a006148-a8","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"O\u2019Brien R.J.","year":"2011","unstructured":"O\u2019Brien R.J.; Wong P.C.; Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 2011,34(1),185-204","journal-title":"Annu Rev Neurosci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","volume":"25","author":"Koenigsknecht-Talboo J.","year":"2005","unstructured":"Koenigsknecht-Talboo J.; Landreth G.E.; Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 2005,25(36),8240-8249","journal-title":"J Neurosci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00415-008-0737-6","volume":"255","author":"Galimberti D.","year":"2008","unstructured":"Galimberti D.; Venturelli E.; Fenoglio C.; Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer\u2019s disease and frontotemporal lobar degeneration. J Neurol 2008,255(4),539-544","journal-title":"J Neurol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","volume":"3","author":"Wang W.Y.","year":"2015","unstructured":"Wang W.Y.; Tan M.S.; Yu J.T.; Tan L.; Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 2015,3(10),136","journal-title":"Ann Transl Med"},{"key":"ref=66","first-page":"55","volume":"49","author":"Cojocaru I.M.","year":"2011","unstructured":"Cojocaru I.M.; Cojocaru M.; Miu G.; Sapira V.; Study of interleukin-6 production in Alzheimer\u2019s disease. Rom J Intern Med 2011,49(1),55-58","journal-title":"Rom J Intern Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/jnen\/59.6.471","volume":"59","author":"Mrak R.E.","year":"2000","unstructured":"Mrak R.E.; Griffin W.S.T.; Interleukin-1 and the immunogenetics of Alzheimer\u2019s disease. J Neuropathol Exp Neurol 2000,59(6),471-476","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nlm.2018.06.006","volume":"155","author":"Bialuk I.","year":"2018","unstructured":"Bialuk I.; Taranta A.; Winnicka M.M.; IL-6 deficiency alters spatial memory in 4- and 24-month-old mice. Neurobiol Learn Mem 2018,155,21-29","journal-title":"Neurobiol Learn Mem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.neuroscience.2009.08.073","volume":"164","author":"Moore A.H.","year":"2009","unstructured":"Moore A.H.; Wu M.; Shaftel S.S.; Graham K.A.; O\u2019Banion M.K.; Sustained expression of interleukin-1\u03b2 in mouse hippocampus impairs spatial memory. Neuroscience 2009,164(4),1484-1495","journal-title":"Neuroscience"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1021\/acschemneuro.8b00511","volume":"10","author":"Prieto G.A.","year":"2019","unstructured":"Prieto G.A.; Smith E.D.; Tong L.; Nguyen M.; Cotman C.W.; Inhibition of LTP-induced translation by IL-1\u03b2 reduces the level of newly synthesized proteins in hippocampal dendrites. ACS Chem Neurosci 2019,10(3),1197-1203","journal-title":"ACS Chem Neurosci"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12603-020-1389-1","volume":"24","author":"Bianchetti A.","year":"2020","unstructured":"Bianchetti A.; Rozzini R.; Guerini F.; Clinical presentation of COVID-19 in dementia patients. J Nutr Health Aging 2020,24(6),560-562","journal-title":"J Nutr Health Aging"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"136675","DOI":"10.1016\/j.neulet.2022.136675","volume":"781","author":"Shkodina A.D.","year":"2022","unstructured":"Shkodina A.D.; Tarianyk K.A.; Boiko D.I.; Cognitive and affective disturbances in patients with Parkinson\u2019s disease: Perspectives for classifying of motor\/neuropsychiatric subtypes. Neurosci Lett 2022,781,136675","journal-title":"Neurosci Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1515\/revneuro-2016-0002","volume":"27","author":"Crouse J.J.","year":"2016","unstructured":"Crouse J.J.; Phillips J.R.; Jahanshahi M.; Moustafa A.A.; Postural instability and falls in Parkinson\u2019s disease. Rev Neurosci 2016,27(5),549-555","journal-title":"Rev Neurosci"},{"key":"ref=74","first-page":"100","volume":"320","author":"Tarianyk K.","year":"2021","unstructured":"Tarianyk K.; Shkodina A.; Lytvynenko N.; Circadian rhythm disorders and non-motor symptoms in different motor subtypes of Parkinson\u2019s disease. Georgian Med News 2021,320,100-106","journal-title":"Georgian Med News"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"P3.057","DOI":"10.1212\/WNL.90.15_supplement.P3.057","volume":"90","author":"Murphy O","year":"2018","unstructured":"Murphy O; Noel J; Farrell M; Lynch T; Support for the spreading hypothesis: pathologically proven alpha-synuclein peripheral neuropathy 20 years before development of Parkinsonism (P3.057). Neurology 2018,90(15 Supplement),P3.057","journal-title":"Neurology"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1091\/mbc.e14-02-0741","volume":"25","author":"Volpicelli-Daley L.A.","year":"2014","unstructured":"Volpicelli-Daley L.A.; Gamble K.L.; Schultheiss C.E.; Riddle D.M.; West A.B.; Lee V.M.Y.; Formation of \u03b1-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes. Mol Biol Cell 2014,25(25),4010-4023","journal-title":"Mol Biol Cell"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","volume":"8","author":"Hall S.","year":"2018","unstructured":"Hall S.; Janelidze S.; Surova Y.; Widner H.; Zetterberg H.; Hansson O.; Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Sci Rep 2018,8(1),13276","journal-title":"Sci Rep"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"Nagatsu T.","year":"2005","unstructured":"Nagatsu T.; Sawada M.; Inflammatory process in Parkinson\u2019s disease: Role for cytokines. Curr Pharm Des 2005,11(8),999-1016","journal-title":"Curr Pharm Des"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","volume":"468","author":"Scalzo P.","year":"2010","unstructured":"Scalzo P.; K\u00fcmmer A.; Cardoso F.; Teixeira A.L.; Serum levels of interleukin-6 are elevated in patients with Parkinson\u2019s disease and correlate with physical performance. Neurosci Lett 2010,468(1),56-58","journal-title":"Neurosci Lett"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","volume":"24","author":"Ferrari C.C.","year":"2006","unstructured":"Ferrari C.C.; Pott Godoy M.C.; Tarelli R.; Chertoff M.; Depino A.M.; Pitossi F.J.; Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1\u03b2 in the substantia nigra. Neurobiol Dis 2006,24(1),183-193","journal-title":"Neurobiol Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/mds.28277","volume":"35","author":"Faber I.","year":"2020","unstructured":"Faber I.; Brand\u00e3o P.R.P.; Menegatti F.; Carvalho Bispo D.D.; Maluf F.B.; Cardoso F.; Coronavirus disease 2019 and Parkinsonism: A non\u2010post\u2010encephalitic case. Mov Disord 2020,35(10),1721-1722","journal-title":"Mov Disord"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1474-4422(20)30305-7","volume":"19","author":"Cohen M.E.","year":"2020","unstructured":"Cohen M.E.; Eichel R.; Steiner-Birmanns B.; A case of probable Parkinson\u2019s disease after SARS-CoV-2 infection. Lancet Neurol 2020,19(10),804-805","journal-title":"Lancet Neurol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"e2109","DOI":"10.1212\/WNL.0000000000010282","volume":"95","author":"M\u00e9ndez-Guerrero A.","year":"2020","unstructured":"M\u00e9ndez-Guerrero A.; Laespada-Garc\u00eda M.I.; G\u00f3mez-Grande A.; Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology 2020,95(15),e2109-e2118","journal-title":"Neurology"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.tins.2020.10.009","volume":"43","author":"Brundin P.","year":"2020","unstructured":"Brundin P.; Nath A.; Beckham J.D.; Is COVID-19 a perfect storm for Parkinson\u2019s disease? Trends Neurosci 2020,43(12),931-933","journal-title":"Trends Neurosci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-020-00123-0","volume":"6","author":"Sulzer D.","year":"2020","unstructured":"Sulzer D.; Antonini A.; Leta V.; COVID-19 and possible links with Parkinson\u2019s disease and parkinsonism: From bench to bedside. NPJ Parkinsons Dis 2020,6(1),18","journal-title":"NPJ Parkinsons Dis"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/brainsci6010006","volume":"6","author":"Mukandala G.","year":"2016","unstructured":"Mukandala G.; Tynan R.; Lanigan S.; O\u2019Connor J.; The effects of hypoxia and inflammation on synaptic signaling in the CNS. Brain Sci 2016,6(1),6","journal-title":"Brain Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/00365519009087509","volume":"50","author":"Zander R.","year":"1990","unstructured":"Zander R.; The oxygen status of arterial human blood. Scand J Clin Lab Invest 1990,50(Sup 203),187-96","journal-title":"Scand J Clin Lab Invest"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"Chen N.","year":"2020","unstructured":"Chen N.; Zhou M.; Dong X.; Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020,395(10223),507-513","journal-title":"Lancet"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1021\/acschemneuro.0c00181","volume":"11","author":"Baig A.M.","year":"2020","unstructured":"Baig A.M.; Updates on what ACS reported: Emerging evidences of COVID-19 with nervous system involvement. ACS Chem Neurosci 2020,11(9),1204-1205","journal-title":"ACS Chem Neurosci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11684-020-0786-5","volume":"14","author":"Li Z.","year":"2020","unstructured":"Li Z.; Liu T.; Yang N.; Neurological manifestations of patients with COVID-19: Potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med 2020,14(5),533-541","journal-title":"Front Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12975-020-00818-9","volume":"11","author":"Hess D.C.","year":"2020","unstructured":"Hess D.C.; Eldahshan W.; Rutkowski E.; COVID-19-related stroke. Transl Stroke Res 2020,11(3),322-325","journal-title":"Transl Stroke Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1093\/neuros\/nyaa186","volume":"87","author":"Daou B.J.","year":"2020","unstructured":"Daou B.J.; Koduri S.; Palmateer G.; Neurological implications of COVID-19 and lessons learned from prior epidemics and pandemics. Neurosurgery 2020,87(2),E234-E238","journal-title":"Neurosurgery"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jinf.2004.09.008","volume":"51","author":"Auyeung T.","year":"2005","unstructured":"Auyeung T.; Lee J.; Lai W.; The use of corticosteroid as treatment in SARS was associated with adverse outcomes: A retrospective cohort study. J Infect 2005,51(2),98-102","journal-title":"J Infect"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/head.13841","volume":"60","author":"Belvis R.","year":"2020","unstructured":"Belvis R.; Headaches during COVID\u201019: My clinical case and review of the literature. Headache 2020,60(7),1422-1426","journal-title":"Headache"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e7352","DOI":"10.7759\/cureus.7352","volume":"12","author":"Filatov A.","year":"2020","unstructured":"Filatov A.; Sharma P.; Hindi F.; Espinosa P.S.; Neurological complications of coronavirus disease (COVID-19): Encephalopathy. Cureus 2020,12(3),e7352","journal-title":"Cureus"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAF.0000000000000129","volume":"36","author":"Nara A.","year":"2015","unstructured":"Nara A.; Nagai H.; Yamaguchi R.; Yoshida K.; Iwase H.; Mizuguchi M.; An unusual autopsy case of cytokine storm-derived influenza-associated encephalopathy without typical histopathological findings: Autopsy case report. Am J Forensic Med Pathol 2015,36(1),3-5","journal-title":"Am J Forensic Med Pathol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cyto.2011.01.006","volume":"54","author":"Hasegawa S.","year":"2011","unstructured":"Hasegawa S.; Matsushige T.; Inoue H.; Shirabe K.; Fukano R.; Ichiyama T.; Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. Cytokine 2011,54(2),167-172","journal-title":"Cytokine"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1442-200X.2003.01822.x","volume":"45","author":"Ichiyama T.","year":"2003","unstructured":"Ichiyama T.; Endo S.; Kaneko M.; Isumi H.; Matsubara T.; Furukawa S.; Serum cytokine concentrations of influenza-associated acute necrotizing encephalopathy. Pediatr Int 2003,45(6),734-736","journal-title":"Pediatr Int"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1752-1947-2-220","volume":"2","author":"Kimura E.","year":"2008","unstructured":"Kimura E.; Okamoto S.; Uchida Y.; A reversible lesion of the corpus callosum splenium with adult influenza-associated encephalitis\/encephalopathy: A case report. J Med Case Reports 2008,2(1),220","journal-title":"J Med Case Reports"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"747","DOI":"10.21203\/rs.3.rs-33179\/v1","volume":"59","author":"Moghimi M.","year":"2021","unstructured":"Moghimi M.; Ghodrati S.; Abbaspourrad Z.; Case report of 78 -year-old man with meningitis, Pulmonary Thromboembolism; SARS-Coronavirus-2 infection. Acta Med Iran 2021,59(12),747-750","journal-title":"Acta Med Iran"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"Moriguchi T.","year":"2020","unstructured":"Moriguchi T.; Harii N.; Goto J.; A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020,94,55-58","journal-title":"Int J Infect Dis"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2169\/internalmedicine.45.1769","volume":"45","author":"Nagafuchi M.","year":"2006","unstructured":"Nagafuchi M.; Nagafuchi Y.; Sato R.; Adult meningism and viral meningitis, 1997-2004: Clinical data and cerebrospinal fluid cytokines. Intern Med 2006,45(21),1209-1212","journal-title":"Intern Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Huang C.","year":"2020","unstructured":"Huang C.; Wang Y.; Li X.; Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020,395(10223),497-506","journal-title":"Lancet"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"Chen G.","year":"2020","unstructured":"Chen G.; Wu D.; Guo W.; Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020,130(5),2620-2629","journal-title":"J Clin Invest"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","volume":"146","author":"Yang Y.","year":"2020","unstructured":"Yang Y.; Shen C.; Li J.; Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol 2020,146(1),119-127.e4","journal-title":"J Allergy Clin Immunol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","volume":"71","author":"Chen X.","year":"2020","unstructured":"Chen X.; Zhao B.; Qu Y.; Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis 2020,71(8),1937-1942","journal-title":"Clin Infect Dis"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Ruan Q.","year":"2020","unstructured":"Ruan Q.; Yang K.; Wang W.; Jiang L.; Song J.; Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020,46(5),846-848","journal-title":"Intensive Care Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"Lippi G.","year":"2020","unstructured":"Lippi G.; Plebani M.; Henry B.M.; Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta 2020,506,145-148","journal-title":"Clin Chim Acta"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"3546118","DOI":"10.2139\/ssrn.3546118","author":"Bai T.","year":"2020","unstructured":"Bai T.; Tu S.; Wei Y.; Clinical and laboratory factors predicting the prognosis of patients with COVID-19: An analysis of 127 patients in Wuhan, China. SSRN Electron J 2020,3546118","journal-title":"SSRN Electron J"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2020.04.046","volume":"87","author":"Zhang J.","year":"2020","unstructured":"Zhang J.; Xie B.; Hashimoto K.; Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immun 2020,87,59-73","journal-title":"Brain Behav Immun"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","volume":"11","author":"Baig A.M.","year":"2020","unstructured":"Baig A.M.; Khaleeq A.; Ali U.; Syeda H.; Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020,11(7),995-998","journal-title":"ACS Chem Neurosci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbi.2020.05.012","volume":"87","author":"Huang Y.H.","year":"2020","unstructured":"Huang Y.H.; Jiang D.; Huang J.T.; SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun 2020,87,149","journal-title":"Brain Behav Immun"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"e00831","DOI":"10.1128\/JVI.00831-20","volume":"94","author":"Zhai X.","year":"2020","unstructured":"Zhai X.; Sun J.; Yan Z.; Comparison of severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts. J Virol 2020,94(15),e00831-e20","journal-title":"J Virol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1615\/CritRevImmunol.v30.i2.20","volume":"30","author":"Hosking M.P.","year":"2010","unstructured":"Hosking M.P.; Lane T.E.; The pathogenesis of murine coronavirus infection of the central nervous system. Crit Rev Immunol 2010,30(2),119-130","journal-title":"Crit Rev Immunol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00415-020-09950-w","volume":"268","author":"Jasti M.","year":"2021","unstructured":"Jasti M.; Nalleballe K.; Dandu V.; Onteddu S.; A review of pathophysiology and neuropsychiatric manifestations of COVID-19. J Neurol 2021,268(6),2007-2012","journal-title":"J Neurol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neurad.2020.05.003","volume":"48","author":"Poillon G.","year":"2021","unstructured":"Poillon G.; Obadia M.; Perrin M.; Savatovsky J.; Lecler A.; Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence? J Neuroradiol 2021,48(2),121-124","journal-title":"J Neuroradiol"},{"key":"ref=117","year":"2021","unstructured":"GSK, after pushing past midphase fail, ends development of otilimab in COVID-19 Fierce BiotechAvailable from: 2021","journal-title":"GSK, after pushing past midphase fail, ends development of otilimab in COVID-19"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.2020.7332","volume":"38","author":"DeKosky S.T.","year":"2021","unstructured":"DeKosky S.T.; Kochanek P.M.; Valadka A.B.; Blood biomarkers for detection of brain injury in COVID-19 patients. J Neurotrauma 2021,38(1),1-43","journal-title":"J Neurotrauma"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/2394-8108.178546","volume":"2","author":"Glushakova O.","year":"2016","unstructured":"Glushakova O.; Glushakov A.; Miller E.; Valadka A.; Hayes R.; Biomarkers for acute diagnosis and management of stroke in neurointensive care units. Brain Circ 2016,2(1),28-47","journal-title":"Brain Circ"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"14703","DOI":"10.1111\/ene.14703","volume":"2021","author":"Virhammar J.","year":"2021","unstructured":"Virhammar J.; N\u00e4\u00e4s A.; F\u00e4llmar D.; Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID\u201019 and associated with neurological symptoms and disease severity. Eur J Neurol 2021,2021,14703","journal-title":"Eur J Neurol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"0000000000010977","DOI":"10.1212\/WNL.0000000000010977","volume":"2020","author":"Ed\u00e9n A.","year":"2020","unstructured":"Ed\u00e9n A.; Kanberg N.; Gostner J.; CSF biomarkers in patients with COVID-19 and neurological symptoms. Neurology 2020,2020,0000000000010977","journal-title":"Neurology"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3174\/ajnr.A6588","volume":"41","author":"Goldberg M.F.","year":"2020","unstructured":"Goldberg M.F.; Goldberg M.F.; Cerejo R.; Tayal A.H.; Cerebrovascular disease in COVID-19. AJNR Am J Neuroradiol 2020,41(7),1170-1172","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","volume":"38","author":"Levi M.","year":"2010","unstructured":"Levi M.; van der Poll T.; Inflammation and coagulation. Crit Care Med 2010,38(2),S26-S34","journal-title":"Crit Care Med"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","volume":"24","author":"Iba T.","year":"2020","unstructured":"Iba T.; Levy J.H.; Connors J.M.; Warkentin T.E.; Thachil J.; Levi M.; The unique characteristics of COVID-19 coagulopathy. Crit Care 2020,24(1),360","journal-title":"Crit Care"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1515\/dx-2020-0078","volume":"7","author":"Franchini M.","year":"2020","unstructured":"Franchini M.; Marano G.; Cruciani M.; COVID-19-associated coagulopathy. Diagnosis (Berl) 2020,7(4),357-363","journal-title":"Diagnosis (Berl)"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1076029620938149","DOI":"10.1177\/1076029620938149","volume":"26","author":"Miesbach W.","year":"2020","unstructured":"Miesbach W.; Makris M.; COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost 2020,26,1076029620938149","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"Tang N.","year":"2020","unstructured":"Tang N.; Bai H.; Chen X.; Gong J.; Li D.; Sun Z.; Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020,18(5),1094-1099","journal-title":"J Thromb Haemost"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"Helms J.","year":"2020","unstructured":"Helms J.; Tacquard C.; Severac F.; High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med 2020,46(6),1089-1098","journal-title":"Intensive Care Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jinf.2020.04.002","volume":"81","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Du X.; Chen J.; Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 2020,81(1),e6-e12","journal-title":"J Infect"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"eaax8847","DOI":"10.1126\/sciadv.aax8847","volume":"6","author":"Vaibhav K.","year":"2020","unstructured":"Vaibhav K.; Braun M.; Alverson K.; Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury. Sci Adv 2020,6(22),eaax8847","journal-title":"Sci Adv"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"100689","DOI":"10.1016\/j.nmni.2020.100689","volume":"35","author":"Earhart A.P.","year":"2020","unstructured":"Earhart A.P.; Holliday Z.M.; Hofmann H.V.; Schrum A.G.; Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome. New Microbes New Infect 2020,35,100689","journal-title":"New Microbes New Infect"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"Alexopoulou L.","year":"2001","unstructured":"Alexopoulou L.; Holt A.C.; Medzhitov R.; Flavell R.A.; Recognition of double-stranded RNA and activation of NF-\u03baB by Toll-like receptor 3. Nature 2001,413(6857),732-738","journal-title":"Nature"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"7670","DOI":"10.4049\/jimmunol.181.11.7670","volume":"181","author":"Ngoi S.M.","year":"2008","unstructured":"Ngoi S.M.; Tovey M.G.; Vella A.T.; Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-\u03b1\/\u03b2. J Immunol 2008,181(11),7670-7680","journal-title":"J Immunol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.1128\/JVI.01410-12","volume":"86","author":"Zhao J.","year":"2012","unstructured":"Zhao J.; Wohlford-Lenane C.; Zhao J.; Intranasal treatment with poly(I\u2022C) protects aged mice from lethal respiratory virus infections. J Virol 2012,86(21),11416-11424","journal-title":"J Virol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"e07863","DOI":"10.1016\/j.heliyon.2021.e07863","volume":"7","author":"Kaidashev I.","year":"2021","unstructured":"Kaidashev I.; Shlykova O.; Izmailova O.; Host gene variability and SARS-CoV-2 infection: A review article. Heliyon 2021,7(8),e07863","journal-title":"Heliyon"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11481-020-09979-8","volume":"16","author":"Paidi R.K.","year":"2021","unstructured":"Paidi R.K.; Jana M.; Mishra R.K.; Dutta D.; Raha S.; Pahan K.; ACE-2-interacting Domain of SARS-CoV-2 (AIDS) peptide suppresses inflammation to reduce fever and protect lungs and heart in mice: Implications for COVID-19 therapy. J Neuroimmune Pharmacol 2021,16(1),59-70","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s13365-020-00895-4","volume":"26","author":"Khatoon F.","year":"2020","unstructured":"Khatoon F.; Prasad K.; Kumar V.; Neurological manifestations of COVID-19: Available evidences and a new paradigm. J Neurovirol 2020,26(5),619-630","journal-title":"J Neurovirol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/brainsci10110852","volume":"10","author":"Tancheva L.","year":"2020","unstructured":"Tancheva L.; Petralia M.C.; Miteva S.; Emerging neurological and psychobiological aspects of COVID-19 infection. Brain Sci 2020,10(11),852","journal-title":"Brain Sci"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S2589-7500(20)30142-4","volume":"2","author":"Whitelaw S.","year":"2020","unstructured":"Whitelaw S.; Mamas M.A.; Topol E.; Van Spall H.G.C.; Applications of digital technology in COVID-19 pandemic planning and response. Lancet Digit Health 2020,2(8),e435-e440","journal-title":"Lancet Digit Health"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abst.2020.08.001","volume":"2","author":"Zhang L.","year":"2020","unstructured":"Zhang L.; Guo H.; Biomarkers of COVID-19 and technologies to combat SARS-CoV-2. Adv Biomarker Sci Technol 2020,2,1-23","journal-title":"Adv Biomarker Sci Technol"},{"key":"ref=141","author":"Bernstein S.","year":"2020","unstructured":"Bernstein S.; The need for neurological disposable tech amid the COVID-19 pandemic Med-Tech Innovation Available from: 2020","journal-title":"The need for neurological disposable tech amid the COVID-19 pandemic Med-Tech Innovation"},{"key":"ref=142","author":"Kaplan E.","year":"2020","unstructured":"Kaplan E.; Industry Voices-Ensuring long-term brain health in the time of COVID-19. Fierce Healthcare Available from: (Accessed on: February 3, 2021).2020"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"E270","DOI":"10.1148\/radiol.2020201933","volume":"297","author":"Mahammedi A.","year":"2020","unstructured":"Mahammedi A.; Saba L.; Vagal A.; Imaging of neurologic disease in hospitalized patients with COVID-19: An Italian multicenter retrospective observational study. Radiology 2020,297(2),E270-E273","journal-title":"Radiology"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.neuroimage.2018.10.003","volume":"197","author":"Davatzikos C.","year":"2019","unstructured":"Davatzikos C.; Machine learning in neuroimaging: Progress and challenges. Neuroimage 2019,197,652-656","journal-title":"Neuroimage"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"104944\/v1","DOI":"10.21203\/rs.3.rs-104944\/v1","author":"Crunfli F.","year":"2020","unstructured":"Crunfli F.; Carregari V.C.; Veras F.P.; SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. MedRxiv 2020,104944\/v1","journal-title":"MedRxiv"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1093\/cid\/ciac153","volume":"75","author":"Sivapalasingam S.","year":"2022","unstructured":"Sivapalasingam S.; Lederer D.J.; Bhore R.; Efficacy and safety of sarilumab in hospitalized patients with coronavirus disease 2019: A randomized clinical trial. Clin Infect Dis 2022,75(1),e380-e388","journal-title":"Clin Infect Dis"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"2102523","DOI":"10.1183\/13993003.02523-2021","volume":"60","author":"Hermine O.","year":"2022","unstructured":"Hermine O.; Mariette X.; Porcher R.; Resche-Rigon M.; Tharaux P.L.; Ravaud P.; Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: Two randomised controlled trials of the CORIMUNO-19 Collaborative Group. Eur Respir J 2022,60(2),2102523","journal-title":"Eur Respir J"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/alz.12556","volume":"18","author":"Frontera J.A.","year":"2022","unstructured":"Frontera J.A.; Boutajangout A.; Masurkar A.V.; Comparison of serum neurodegenerative biomarkers among hospitalized COVID\u201019 patients versus non\u2010COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer\u2019s dementia. Alzheimers Dement 2022,18(5),899-910","journal-title":"Alzheimers Dement"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.2174\/0929867033456918","volume":"10","author":"Aarli J.","year":"2003","unstructured":"Aarli J.; Role of cytokines in neurological disorders. Curr Med Chem 2003,10(19),1931-1937","journal-title":"Curr Med Chem"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220908084559","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208628\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220908084559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T17:26:39Z","timestamp":1727976399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208628\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":149,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205019666220908084559","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}